Therapeutic Drug Monitoring in Inflammatory Bowel Disease History and Future Directions

被引：16

作者：

Spencer, Elizabeth A. ^{[1
]}

Dubinsky, Marla C. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Pediat Gastroenterol & Hepatol, Dept Pediat, Susan & Leonard Feinstein IBD Clin Ctr,Mt Sinai H, 1 Gustave L Levy Pl,Box 1656, New York, NY 10029 USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 2017年 / 64卷 / 06期

关键词：

Inflammatory bowel disease; Therapeutic drug monitoring; Thiopurine metabolite monitoring; Biologics; SEVERE ULCERATIVE-COLITIS; ANTI-TNF THERAPY; THIOPURINE S-METHYLTRANSFERASE; PATIENTS LOSING RESPONSE; INFLIXIMAB TROUGH LEVELS; QUALITY-OF-LIFE; CROHNS-DISEASE; MAINTENANCE THERAPY; PEDIATRIC-PATIENTS; INDUCTION THERAPY;

D O I：

10.1016/j.pcl.2017.08.008

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Clinical trials for the most effective drugs in the armamentarium of medications for inflammatory bowel disease (IBD) have shown only a 50% to 60% response rate, and this drops to 30% in maintenance. However, therapeutic drug monitoring (TDM) to adjust dosing to account for patient-specific characteristics, which has been shown to improve outcomes, was not used in these trials. This article details the development of TDM within the IBD space as it evolved from thiopurines to biologics and continues to evolve with loftier treat-to-target goals and more sophisticated dashboard systems.

引用

页码：1309 / +

页数：19

共 97 条

[1]

Adedokun OJ, 2016, GASTROENTEROLOGY, V150, pS408

[2]

Adedokun OJ, 2017, J CROHNS COLITIS, V11, P35, DOI 10.1093/ecco-jcc/jjw133

[3] Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease [J].

Afif, Waqqas ;

Loftus, Edward V., Jr. ;

Faubion, William A. ;

Kane, Sunanda V. ;

Bruining, David H. ;

Hanson, Karen A. ;

Sandborn, William J. .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05) :1133-1139

[4] Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects [J].

Allez, Matthieu ;

Karmiris, Konstantinos ;

Louis, Edouard ;

Van Assche, Gert ;

Ben-Horin, Shomron ;

Klein, Amir ;

Van der Woude, Janneke ;

Baert, Filip ;

Eliakim, Rami ;

Katsanos, Konstantinos ;

Brynskov, Jorn ;

Steinwurz, Flavio ;

Danese, Silvio ;

Vermeire, Severine ;

Teillaud, Jean-Luc ;

Lemann, Marc ;

Chowers, Yehuda .

JOURNAL OF CROHNS & COLITIS, 2010, 4 (04) :355-366

[5]

[Anonymous], J GASTROENTEROL

[6] Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease [J].

Battat, Robert ;

Kopylov, Uri ;

Bessissow, Talat ;

Bitton, Alain ;

Cohen, Albert ;

Jain, Anjali ;

Martel, Myriam ;

Seidman, Ernest ;

Afif, Waqqas .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (09) :1427-+

[7] Review article: loss of response to anti-TNF treatments in Crohn's disease [J].

Ben-Horin, S. ;

Chowers, Y. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (09) :987-995

[8] Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima [J].

Ben-Horin, Shomron ;

Yavzori, Miri ;

Benhar, Itai ;

Fudim, Ella ;

Picard, Orit ;

Ungar, Bella ;

Lee, SooYoung ;

Kim, SungHwan ;

Eliakim, Rami ;

Chowers, Yehuda .

GUT, 2016, 65 (07) :1132-1138

[9] Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease [J].

Ben-Horin, Shomron ;

Waterman, Matti ;

Kopylov, Uri ;

Yavzori, Miri ;

Picard, Orit ;

Fudim, Ella ;

Awadie, Halim ;

Weiss, Batia ;

Chowers, Yehuda .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (04) :444-447

[10] Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis [J].

Brandse, Johannan F. ;

van den Brink, Gijs R. ;

Wildenberg, Manon E. ;

van der Kleij, Desiree ;

Rispens, Theo ;

Jansen, Jeroen M. ;

Mathot, Ron A. ;

Ponsioen, Cyriel Y. ;

Lowenberg, Mark ;

D'Haens, Geert R. A. M. .

GASTROENTEROLOGY, 2015, 149 (02) :350-+

← 1 2 3 4 5 6 7 8 9 10 →